B-CPAP Human Thyroid Cancer Cells (poorly Differentiated)

Human papillary thyroid carcinoma (PTC) B-CPAP was established in 1992 from the tumor tissue of a 76-year-old woman with metastatic papillary thyroid carcinoma. Initially classified as papillary thyroid carcinoma (PTC), it is now considered as poorly differentiated thyroid carcinoma

Tissue and Cell Type: thyroid, thyroid tumor

Morphology: spindle or round cells, adherent growth

Culture media and additives/Complete Growth Medium and Culture Conditions:

90% DMEM high glucose (MD0100)+10% fetal bovine serum (SD0200)+G/A (SD0038)

Complete medium: DMEM high-sugar medium (article number: MD0101)

Gas phase: air, 95%; Carbon dioxide, 5%. Temperature: 37 ℃.

Freezing conditions: basic medium+5% DMSO+20% FBS

Complete cryopreservation solution: non-programmed cooling cell cryopreservation solution (low serum) (SD0001)

Note: The product is only for scientific research.

PubMed=9054892; DOI=10.1016/S0360-3016(96)00449-X

Challeton C., Branea F., Schlumberger M., Gaillard N., de Vathaire F., Badie C., Antonini P., Parmentier C.

Characterization and radiosensitivity at high or low dose rate of four cell lines derived from human thyroid tumors.

Int. J. Radiat. Oncol. Biol. Phys. 37:163-169(1997)

PubMed=17725429; DOI=10.1089/thy.2007.0097

Meireles A.M., Preto A., Rocha A.S., Rebocho A.P., Maximo V., Pereira-Castro I., Moreira S., Feijao T., Botelho T., Marques R., Trovisco V., Cirnes L., Alves C., Velho S., Soares P., Sobrinho-Simoes M.

Molecular and genotypic characterization of human thyroid follicular cell carcinoma-derived cell lines.

Thyroid 17:707-715(2007)

PubMed=18713817; DOI=10.1210/jc.2008-1102

Schweppe R.E., Klopper J.P., Korch C., Pugazhenthi U., Benezra M., Knauf J.A., Fagin J.A., Marlow L.A., Copland J.A., Smallridge R.C., Haugen B.R.

Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification.

J. Clin. Endocrinol. Metab. 93:4331-4341(2008)

PubMed=19087340; DOI=10.1186/1471-2407-8-371

Ribeiro F.R., Meireles A.M., Rocha A.S., Teixeira M.R.

Conventional and molecular cytogenetics of human non-medullary thyroid carcinoma: characterization of eight cell line models and review of the literature on clinical samples.

BMC Cancer 8:371-371(2008)

PubMed=20143388; DOI=10.1002/ijc.25242

Capes-Davis A., Theodosopoulos G., Atkin I., Drexler H.G., Kohara A., MacLeod R.A.F., Masters J.R.W., Nakamura Y., Reid Y.A., Reddel R.R., Freshney R.I.

Check your cultures! A list of cross-contaminated or misidentified cell lines.

Int. J. Cancer 127:1-8(2010)

PubMed=22087789; DOI=10.1186/1755-8166-4-26

Maric I., Viaggi S., Caria P., Frau D.V., Degan P., Vanni R.

Centrosomal and mitotic abnormalities in cell lines derived from papillary thyroid cancer harboring specific gene alterations.

Mol. Cytogenet. 4:26-26(2011)

PubMed=23162534; DOI=10.3389/fendo.2012.00133

Saiselet M., Floor S., Tarabichi M., Dom G., Hebrant A., van Staveren W.C.G., Maenhaut C.

Thyroid cancer cell lines: an overview.

Front. Endocrinol. 3:133-133(2012)

PubMed=25675381; DOI=10.1210/jc.2014-2764

von Roemeling C.A., Marlow L.A., Pinkerton A.B., Crist A., Miller J., Tun H.W., Smallridge R.C., Copland J.A.

Aberrant lipid metabolism in anaplastic thyroid carcinoma reveals stearoyl CoA desaturase 1 as a novel therapeutic target.

J. Clin. Endocrinol. Metab. 100:E697-E709(2015)

PubMed=30737244; DOI=10.1158/1078-0432.CCR-18-2953

Landa I., Pozdeyev N., Korch C., Marlow L.A., Smallridge R.C., Copland J.A., Henderson Y.C., Lai S.Y., Clayman G.L., Onoda N., Tan A.C., Garcia-Rendueles M.E.R., Knauf J.A., Haugen B.R., Fagin J.A., Schweppe R.E.

Comprehensive genetic characterization of human thyroid cancer cell lines: a validated panel for preclinical studies.

Clin. Cancer Res. 25:3141-3151(2019)

LncRNA GLTC targets LDHA for succinylation and enzyme activity to promote differentiated thyroid cancer progression and radioiodine resistance ，DOI: https://doi.org/10.21203/rs.3.rs-1949475/v1

LncRNA GLTC targets LDHA for succinylation and enzymatic activity to promote progression and radioiodine resistance in papillary thyroid cancer；Cell Death & Differentiation volume 30, pages1517–1532 (2023)